Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 50% Gains Investing -- Ignore unavailable to you. Want to Upgrade?

To: Dale Baker who wrote (29444)	2/26/2002 10:44:44 PM
From: Londo	Read Replies (1) \| Respond to of 118717

>> holding the GILD short I will add to if it gets close to 70 << From what I know of GILD's "personality", it looks like that you're not the only other person betting against the company - the "cycle" between the mid 60's and the high 60's has been going on for too long, and considering the short biases that are out there on the stock, I suspect swing trading it will be progressively more challenging. In fact, I'm anticipating that they're going to have another run-up, similar to what they had from April to June in 2001. The fundamental story with GILD is one of flawless execution. Strictly in terms of numbers, they'll have three drugs (Tenofovir, Adefovir, Amphotericin B) producing a billion in sales by 2005. If the execution is clean, the company should probably see a 10-12 billion dollar market cap in a couple years.